- Moderna Inc. began testing an experimental HIV vaccine based on its mRNA technology. The company plans to monitor 56 HIV-negative adults in the U.S. for six months in the Phase 1 clinical trial. Previous efforts to develop HIV vaccines have failed, and the illness still causes hundreds of thousands of deaths annually across the globe. (Article here)
February 2, 2022
Life Sciences